Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9824, pp. 1393 - 1402
Summary Background The relative safety of drug-eluting stents and bare-metal stents, especially with respect to stent thrombosis, continues to be debated. In...
Internal Medicine | RECOVERY | TRIALS | MEDICINE, GENERAL & INTERNAL | CORONARY | SAFETY | PREDICTORS | LESIONS | Angioplasty, Balloon, Coronary - instrumentation | Prognosis | Humans | Male | Drug-Eluting Stents - adverse effects | Incidence | Angioplasty, Balloon, Coronary - adverse effects | Prosthesis Failure | Female | Coronary Restenosis - etiology | Coronary Stenosis - diagnostic imaging | Sirolimus - therapeutic use | Coronary Stenosis - therapy | Risk Assessment | Thrombosis - epidemiology | Evidence-Based Medicine | Paclitaxel - therapeutic use | Randomized Controlled Trials as Topic | Radiography | Coronary Restenosis - epidemiology | Thrombosis - etiology | Survival Analysis | Italy | Coronary Stenosis - mortality | Stents - adverse effects | Complications and side effects | Usage | Research | Comparative analysis | Thrombosis | Blood clot | Risk factors | Stent (Surgery) | Studies | Fees & charges | Heart attacks | Statistical analysis | Meetings | Clinical trials | FDA approval | Stents | Meta-analysis
Internal Medicine | RECOVERY | TRIALS | MEDICINE, GENERAL & INTERNAL | CORONARY | SAFETY | PREDICTORS | LESIONS | Angioplasty, Balloon, Coronary - instrumentation | Prognosis | Humans | Male | Drug-Eluting Stents - adverse effects | Incidence | Angioplasty, Balloon, Coronary - adverse effects | Prosthesis Failure | Female | Coronary Restenosis - etiology | Coronary Stenosis - diagnostic imaging | Sirolimus - therapeutic use | Coronary Stenosis - therapy | Risk Assessment | Thrombosis - epidemiology | Evidence-Based Medicine | Paclitaxel - therapeutic use | Randomized Controlled Trials as Topic | Radiography | Coronary Restenosis - epidemiology | Thrombosis - etiology | Survival Analysis | Italy | Coronary Stenosis - mortality | Stents - adverse effects | Complications and side effects | Usage | Research | Comparative analysis | Thrombosis | Blood clot | Risk factors | Stent (Surgery) | Studies | Fees & charges | Heart attacks | Statistical analysis | Meetings | Clinical trials | FDA approval | Stents | Meta-analysis
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1025 - 1034
Summary Background Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y12 inhibitor prevents ischaemic events after coronary stenting, but increases...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | CLOPIDOGREL | EFFICACY | BARE-METAL STENTS | RISK STRATIFICATION | GUIDELINES | ACUTE MYOCARDIAL-INFARCTION | ACUTE CORONARY SYNDROMES | DURATION | DRUG-ELUTING STENTS | Medical policy | Complications and side effects | Medical research | Medical colleges | Aspirin | Clinical trials | Medicine, Experimental | Cardiology | Medicine, Preventive | Stent (Surgery) | Preventive health services | Anticoagulants | Heart attacks | Cardiovascular disease | Hemorrhage | Thrombosis | Patients | Risk assessment | Coronary vessels | Clinical medicine | Acute coronary syndromes | Stents | Age | Medical and Health Sciences | Medicin och hälsovetenskap
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | CLOPIDOGREL | EFFICACY | BARE-METAL STENTS | RISK STRATIFICATION | GUIDELINES | ACUTE MYOCARDIAL-INFARCTION | ACUTE CORONARY SYNDROMES | DURATION | DRUG-ELUTING STENTS | Medical policy | Complications and side effects | Medical research | Medical colleges | Aspirin | Clinical trials | Medicine, Experimental | Cardiology | Medicine, Preventive | Stent (Surgery) | Preventive health services | Anticoagulants | Heart attacks | Cardiovascular disease | Hemorrhage | Thrombosis | Patients | Risk assessment | Coronary vessels | Clinical medicine | Acute coronary syndromes | Stents | Age | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9908, pp. 1879 - 1888
Summary Background The safety and efficacy of drug-eluting stents (DES) in the treatment of coronary artery disease have been assessed in several randomised...
Internal Medicine | METIS-302438 | IR-89428 | SLOW-RELEASE | MEDICINE, GENERAL & INTERNAL | BIODEGRADABLE POLYMER | BARE-METAL STENTS | LONG-TERM OUTCOMES | NON-INFERIORITY TRIAL | DOUBLE-BLIND | FOLLOW-UP | DURABLE POLYMER | CORONARY-ARTERY-DISEASE | NETWORK METAANALYSIS | Myocardial Infarction - mortality | Humans | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Restenosis - therapy | Drug-Eluting Stents - adverse effects | Randomized Controlled Trials as Topic | Coronary Restenosis - epidemiology | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - methods | Thrombosis - etiology | Sex Factors | Female | Thrombosis - mortality | Myocardial Infarction - etiology | Women | Care and treatment | Coronary heart disease | Health aspects | Drug-eluting stents | Studies | Heart attacks | Coronary vessels | Cardiovascular disease | Random variables | Gender | Acute coronary syndromes | Stents | Thrombosis | Patients
Internal Medicine | METIS-302438 | IR-89428 | SLOW-RELEASE | MEDICINE, GENERAL & INTERNAL | BIODEGRADABLE POLYMER | BARE-METAL STENTS | LONG-TERM OUTCOMES | NON-INFERIORITY TRIAL | DOUBLE-BLIND | FOLLOW-UP | DURABLE POLYMER | CORONARY-ARTERY-DISEASE | NETWORK METAANALYSIS | Myocardial Infarction - mortality | Humans | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Restenosis - therapy | Drug-Eluting Stents - adverse effects | Randomized Controlled Trials as Topic | Coronary Restenosis - epidemiology | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - methods | Thrombosis - etiology | Sex Factors | Female | Thrombosis - mortality | Myocardial Infarction - etiology | Women | Care and treatment | Coronary heart disease | Health aspects | Drug-eluting stents | Studies | Heart attacks | Coronary vessels | Cardiovascular disease | Random variables | Gender | Acute coronary syndromes | Stents | Thrombosis | Patients
Journal Article
Cell Stem Cell, ISSN 1934-5909, 04/2016, Volume 18, Issue 4, pp. 508 - 521
Hematopoiesis is regulated by crosstalk between long-term repopulating hematopoietic stem cells (LT-HSCs) and supporting niche cells in the bone marrow (BM)....
stem cell niche | CD82/KAI1 | tetraspanin | DARC/CD234 | quiescence | macrophage | LT-HSCs | bone marrow | PROGENITOR CELLS | CD34(-) | BONE-MARROW NICHE | QUIESCENCE | VASCULAR NICHE | SELF-RENEWAL | RECEPTOR | IDENTIFICATION | KAI1 | METASTASIS SUPPRESSOR GENE | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Humans | Mice, Inbred C57BL | Receptors, Cell Surface - metabolism | Male | Mice, Transgenic | Hematopoietic Stem Cells - metabolism | Kangai-1 Protein - deficiency | Mice, Knockout | Macrophages - metabolism | Animals | Kangai-1 Protein - metabolism | Duffy Blood-Group System - metabolism | Female | Mice | Kangai-1 Protein - biosynthesis
stem cell niche | CD82/KAI1 | tetraspanin | DARC/CD234 | quiescence | macrophage | LT-HSCs | bone marrow | PROGENITOR CELLS | CD34(-) | BONE-MARROW NICHE | QUIESCENCE | VASCULAR NICHE | SELF-RENEWAL | RECEPTOR | IDENTIFICATION | KAI1 | METASTASIS SUPPRESSOR GENE | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Humans | Mice, Inbred C57BL | Receptors, Cell Surface - metabolism | Male | Mice, Transgenic | Hematopoietic Stem Cells - metabolism | Kangai-1 Protein - deficiency | Mice, Knockout | Macrophages - metabolism | Animals | Kangai-1 Protein - metabolism | Duffy Blood-Group System - metabolism | Female | Mice | Kangai-1 Protein - biosynthesis
Journal Article
Cardiology, ISSN 0008-6312, 01/2015, Volume 130, Issue 1, pp. 4 - 14
Objectives: This meta-analysis investigated the impact of renin-angiotensin-aldosterone system (RAAS) blockade on the occurrence of contrast-induced...
Original Research | Renin | Contrast media | Kidney | Angiotensin | Meta-analysis | ACUTE KIDNEY INJURY | CARDIAC & CARDIOVASCULAR SYSTEMS | RECEPTOR BLOCKERS | RISK | CONVERTING ENZYME-INHIBITORS | ACE-INHIBITORS | THERAPY | DISEASE | Contrast Media - adverse effects | Humans | Angiotensin Receptor Antagonists - pharmacology | Renin-Angiotensin System - drug effects | Acute Kidney Injury - chemically induced | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Acute Kidney Injury - prevention & control | Contrast agents | Kidney diseases | Cardiology | ACE inhibitors
Original Research | Renin | Contrast media | Kidney | Angiotensin | Meta-analysis | ACUTE KIDNEY INJURY | CARDIAC & CARDIOVASCULAR SYSTEMS | RECEPTOR BLOCKERS | RISK | CONVERTING ENZYME-INHIBITORS | ACE-INHIBITORS | THERAPY | DISEASE | Contrast Media - adverse effects | Humans | Angiotensin Receptor Antagonists - pharmacology | Renin-Angiotensin System - drug effects | Acute Kidney Injury - chemically induced | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Acute Kidney Injury - prevention & control | Contrast agents | Kidney diseases | Cardiology | ACE inhibitors
Journal Article
Diabetes, ISSN 0012-1797, 02/2011, Volume 60, Issue 2, pp. 496 - 506
OBJECTIVE--Peroxisome proliferator--activated receptor (PPAR)-[alpha]/[gamma] dual agonists have been developed to alleviate metabolic disorders. However,...
Glucose metabolism | Cell receptors | Fatty acid metabolism | Physiological aspects | Metabolic diseases | Genetic aspects | Research | Drug therapy
Glucose metabolism | Cell receptors | Fatty acid metabolism | Physiological aspects | Metabolic diseases | Genetic aspects | Research | Drug therapy
Journal Article
Journal of Vascular Research, ISSN 1018-1172, 08/2007, Volume 44, Issue 5, pp. 434 - 434
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.